Elisabeth Souhami

Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia

Roger A. Fielding, Bruno Vellas, William J. Evans et al. · Journal of the American Medical Directors Association · 2011 · 3.3K citations

Medicine, Geriatric Medicine, Geriatrics +16

Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial

Julio Rosenstock, Ronnie Aronson, George Grunberger et al. · Diabetes Care · 2016 · 268 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial

Vanita R. Aroda, Julio Rosenstock, Carol Wysham et al. · Diabetes Care · 2016 · 256 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine

Matthew C. Riddle, Thomas Först, Ronnie Aronson et al. · Diabetes Care · 2013 · 251 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

Julio Rosenstock, Bruno Guerci, M Hanefeld et al. · Diabetes Care · 2016 · 131 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17